Clinical implication and immunological landscape analyses of ANLN in pan-cancer: A new target for cancer research.
Lan ZhangYong WeiYan HeXiaping WangZebo HuangLibing SunJie ChenQingyi ZhuXin Zhou
Published in: Cancer medicine (2022)
ANLN may serve as a prognostic biomarker for pan-cancer. ANLN upregulation is associated with higher TMB, MSI, and immune cell infiltration in multiple types of tumors, shedding new light for cancer treatment.